Back to search results

Mobile Regulation of Craving Training (mROC-T) for Adolescent Girls

This study is testing a mobile app called Mobile Regulation of Craving Training (mROC-T) to see if it can help adolescent girls in rural areas eat healthier. The app aims to increase how many fruits and vegetables you eat. Researchers want to know if using the mROC-T app improves your Healthy Eating Index (a score of how healthy your diet is) and also affects your body mass index (BMI), waist size, and blood sugar levels over one year. You would be randomized (like drawing names from a hat) into one of two active mROC-T groups or a control group that gets fun food facts. This study is for girls aged 15 to 18 years old who are biologically female. The study is currently unclear on its recruitment status and plans to enroll 150 participants.

Study design
This is an interventional study where participants are randomly assigned to either an active mROC-T group or a control group. It aims to enroll 150 adolescent girls.
What's involved
You would have in-person visits at the beginning and after one year, which include blood tests (oral glucose tolerance test), measurements of height, weight, and waist circumference, and completing questionnaires. You will also play the mROC-T game and record your diet.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for one year after the initial visit.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06723028

Mobile Regulation of Craving Training (mROC-T) to Improve Dietary Intake in Rural Adolescent Girls

Active, Not Recruiting
NAAges 15–18InterventionalPrevention
University of Wyoming
~150 participants
Updated 2026-05-05 on ClinicalTrials.gov
What's tested:Regulation of craving training

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Healthy eating index (HEI)
Measured over 1 year

Conditions

Obesity and Type 2 Diabetes
Diet Modification

Explore related trials

ObesityType 2 Diabetes Mellitus

Where it's being run

1 sites across 1 states
Wyoming1

Study leadership

  • Grace Shearrer, PhD · PRINCIPAL_INVESTIGATOR · University of Wyoming

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Biologically female
Female gender
Between the ages of 15y and 18y

Exclusion

Biologically male
Self-identify as male
BMI percentile (for age and sex) \< 5th%
Diagnosis from a medical profession of any of the following conditions, syndromes, diseases that may affect growth, glucose metabolism, blood clotting, cognitive development\*:
Any form of or history of cancer
Any form of diabetes (type I, II, insipidus)
Precocious puberty
Crohn's disease
Congenital heart defect
Cystic fibrosis
Cerebral palsy
Anorexia nervosa
Bulimia nervosa
Active infection
Fever
Hemophilia
Hydrocephalus
intestinal atresia
Jeune syndrome
Klippel-Trénaunay syndrome
Legg-Calvé-Perthes
Long QT syndrome
Muenke syndrome
Myelomeningocele
Necrotizing Enterocolitis
Neutropenia
Non-alcholoic fatty liver diease
Pfeiffer Syndrome
Saethre-Chotzen syndrome
Shwachman-Diamond syndrome
Spinal muscular atrophy
Sturge-Weber syndrome
Ulcerative Colitis
von Willebrand disease
Pancreatitis
Hurler syndrome
Niemann-Pick disease
Tay-Sachs disease
Gaucher disease
Krabbe disease
Zellweger syndrome
Wilson disease
Brachial Plexus Palsy
Brain Abscess or Spinal Abscess
Coarctation of the Aorta
Aortic stenosis
Ventricular septal defect
Patent ductus arteriosus or mitral valve abnormalities
Congenital Adrenal Hyperplasia
Craniofacial Microsomia
Duchenne Muscular Dystrophy
Dyskeratosis Congenita
Galactosemia
Maple syrup urine disease
Phenylketonuria
Turner syndrome
Prader-Wili disease
History of polycystic ovary syndrome
History of thyroid disease (either hyper or hypo)
History of adrenal disease (including Cushing's syndrome, Addison's disease)
Use of medications related to metabolism/weight such as insulin, corticosteroids, growth hormone, sulfonylurea, thiazolidinediones, beta blockers, calcium channel blockers, bupropion, reboxetine, molindone, clozapine, olanzapine, topiramate, zonisamide, valproate, carbamazepine, lithium, hypolipidemic drugs, highly-active antiretroviral therapies

What this trial measures

  • Healthy eating index (HEI)1 year

    Participants will provide diet recalls twice per month. The participants will complete the diet recalls using the Automated Self Administered 24 hour recall (ASA-24) platform. The ASA-24 computes the necessary variables to calculate the healthy eating index (HEI). HEI is a measure of overall diet quality according to the Dietary Guidelines for Americans and is scored from 0-100 (100 being the best possible diet). HEI scores will be calculated per month (mean of diet recalls per person) using the most recent HEI scoring algorithm as recommended for intervention studies.